Showing results (81-90 of 245) with videos related to
Sort By:
Pageof 25
Journal of the American College of Cardiology|March 30, 2002
Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000Richard E Shaw, H Vernon Anderson, Ralph G Brindis, et al.The Journal of Invasive Cardiology|October 2, 2003
Updated risk adjustment mortality model using the complete 1.1 dataset from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR)Richard E Shaw, H Vernon Anderson, Ralph G Brindis, et al.Journal of the American College of Cardiology|July 12, 2014
Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trialLars G Svensson, Eugene H Blackstone, Jeevanantham Rajeswaran, et al.Annals of the Rheumatic Diseases|November 1, 2011
Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumabCarrie Wagner, Sudha Visvanathan, Jürgen Braun, et al.Arthritis Research & Therapy|November 19, 2010
Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD studySudha Visvanathan, Mahboob U Rahman, Edward Keystone, et al.JACC. Cardiovascular Interventions|October 23, 2017
Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-AnalysisMarwan Saad, Ramez Nairooz, Naga Venkata K Pothineni, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 12, 2023
Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysisWaqas Ullah, Deepika Sarvepalli, Arnav Kumar, et al.The Journal of Rheumatology|June 3, 2009
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapySudha Visvanathan, Carrie Wagner, Jeannie Rojas, et al.Arthritis Care & Research|May 28, 2010
Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trialAtul Deodhar, Jürgen Braun, Robert D Inman, et al.The Heart Surgery Forum|February 26, 2004
On-Pump Beating Heart Surgery Offers an Alternative for Unstable Patients Undergoing Coronary Artery Bypass GraftingJames R. Edgerton, Morley A. Herbert, Katherine K. Jones, et al.Pageof 25